Imunon, Inc. Faces Delisting Notice
Ticker: IMNN · Form: 8-K · Filed: May 30, 2025 · CIK: 749647
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Imunon (IMNN) got a delisting warning from the exchange.
AI Summary
Imunon, Inc. filed an 8-K on May 30, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Celsion Corp, is incorporated in Delaware and has its principal executive offices in Lawrenceville, NJ.
Why It Matters
This filing indicates potential issues with Imunon, Inc.'s continued listing on an exchange, which could significantly impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Imunon, Inc. (company) — Registrant
- Celsion Corp (company) — Former company name
- May 30, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Lawrenceville, NJ (location) — Principal executive office location
FAQ
What is the specific reason for Imunon, Inc.'s notice of delisting or failure to satisfy a continued listing rule?
The filing does not specify the exact reason for the delisting notice, only that it is a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing'.
When was this 8-K report filed?
The 8-K report was filed on May 30, 2025.
What were Imunon, Inc.'s former names?
Imunon, Inc. was formerly known as Celsion Corp (twice) and Cheung Laboratories Inc.
Where are Imunon, Inc.'s principal executive offices located?
Imunon, Inc.'s principal executive offices are located at 997 Lenox Drive, Suite 100, Lawrenceville, NJ 08648-2311.
What is Imunon, Inc.'s state of incorporation?
Imunon, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Imunon, Inc. (IMNN).